UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.343

Sortiert nach

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers

Frontiers in oncology, 2018-10, Vol.8, p.423-423

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases

Frontiers in oncology, 2021-06, Vol.11, p.667468-667468

2021

Link zum Volltext

Verfügbarkeit prüfen

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

Frontiers in oncology, 2022-11, Vol.12, p.996554-996554

2022

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines

International journal of molecular sciences, 2020-12, Vol.21 (23), p.9307

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

Journal of clinical oncology, 2010-07, Vol.28 (20), p.3330-3335

2010

Link zum Volltext

Verfügbarkeit prüfen

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

International journal of molecular sciences, 2017-12, Vol.19 (1), p.107

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2735-2743

2014

Link zum Volltext

Verfügbarkeit prüfen

A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer

Frontiers in oncology, 2014-01, Vol.4, p.271-271

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies

Clinical cancer research, 2006-02, Vol.12 (4), p.1251-1259

2006

Link zum Volltext

Verfügbarkeit prüfen

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

Frontiers in oncology, 2016-01, Vol.5, p.301

2016

Link zum Volltext

Verfügbarkeit prüfen

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Clinical Medicine Insights. Oncology, 2012-01, Vol.2012 (6), p.137-147

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer

Journal of thoracic oncology, 2010-05, Vol.5 (5), p.673-679

2010

Link zum Volltext

Verfügbarkeit prüfen

PS01.33: Change in microRNA Profile in Lung Cancer Cell Treated with Chemotherapy Cisplatin (C), Pemetrexed (P) or PC with Bevacizumab (B): Topic: Medical Oncology

Journal of thoracic oncology, 2016-11, Vol.11 (11), p.S289-S289

2016

Link zum Volltext

Verfügbarkeit prüfen

Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer

Thoracic cancer, 2016-01, Vol.7 (1), p.66-71

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of previous anti-angiogenesis treatment in nivolumab-treated advanced non-small cell lung cancer

Journal of cancer metastasis and treatment, 2018-01, Vol.4 (1), p.1

2018

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer management in 2010

Oncology (Williston Park, N.Y.), 2011-01, Vol.25 (1), p.64-73

2011

Link zum Volltext

Verfügbarkeit prüfen

Potential Role of Platelet-Derived Growth Factor Receptor Inhibition Using Imatinib in Combination with Docetaxel in the Treatment of Recurrent Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-02, Vol.6 (2), p.372-377

2011

Link zum Volltext

Verfügbarkeit prüfen

Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lung cancer

Thoracic cancer, 2014-11, Vol.5 (6), p.565-569

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 777: Down-regulation of miR-506 contributes to EGFR-TKI resistance through inducing sonic hedgehog signaling in non-small cell lung cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.777-777

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 485: Modulation of microRNA expression in EGFR-tyrosine kinase inhibitor-resistant non-small cell lung cancer cell lines

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.485-485

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1481: Determination of microRNA profile in lung cancer cell line treated with chemotherapy cisplatin (C), pemetrexed (P) or PC with bevacizumab (B) and its implication in resistance

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1481-1481

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4528: Comparison of anti-proliferation activity of BEZ 235, a multi-step inhibitor of mTOR pathway, vs. BKM120, a pan PI3K inhibitor, in lung cancer cell lines (LCCL)

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4528-4528

2014

Link zum Volltext

Verfügbarkeit prüfen

Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1–specific TCR T-cells in HLA-A02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2)

JOURNAL OF CLINICAL ONCOLOGY, 2021, Vol.39 (15_suppl), p.TPS2661-TPS2661

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2947: MicroRNA 10b, 27a and 27b are involved in the resistance to treatment with epidermal growth factor tyrosine inhibitor (EGFR-TKI) in EGFR mutant lung cancer cell line

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2947-2947

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.343

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.897)
Mit Volltextzugriff
(4.047)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.668)
Life Sciences & Biomedicine
(1.228)
Physics
(1.146)
Physical Sciences
(970)
Humans
(883)
Technology
(753)
Physics Of Elementary Particles And Fields
(702)
Female
(580)
Male
(531)
Biological And Medical Sciences
(509)
Hadron-Hadron Scattering
(484)
Physics And Astronomy
(429)
Physics, Particles & Fields
(426)
Elementary Particles
(425)
String Theory
(417)
Medical Sciences
(416)
Quantum Field Theories
(416)
Quantum Field Theory
(416)
Engineering
(400)
Regular Article - Experimental Physics
(394)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of High Energy Physics
(599)
The European Physical Journal. C, Particles And Fields
(403)
Physics Letters. B
(258)
Physical Review Letters
(155)
Physical Review. D
(84)
Jhep
(47)
Advanced Materials Research
(28)
Journal Of Instrumentation
(26)
Eur.Phys.J.C
(24)
Phys.Lett.B
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Updates in the Clinical Development of Epacadostat and Other Indoleamine 2,3-Dioxygenase 1 Inhibitors (IDO1) for Human Cancers

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?

Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

A multicenter pilot study examining the role of circulating tumor cells as a blood-based tumor marker in patients with extensive small-cell lung cancer

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies

Impact Study: MK-0646 (Dalotuzumab), Insulin Growth Factor 1 Receptor Antibody Combined with Pemetrexed and Cisplatin in Stage IV Metastatic Non-squamous Lung Cancer

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked

PS01.33: Change in microRNA Profile in Lung Cancer Cell Treated with Chemotherapy Cisplatin (C), Pemetrexed (P) or PC with Bevacizumab (B): Topic: Medical Oncology

Systematic analysis of design and stratification for phase III trials in first‐line advanced non‐small cell lung cancer

Impact of previous anti-angiogenesis treatment in nivolumab-treated advanced non-small cell lung cancer

Lung cancer management in 2010

Potential Role of Platelet-Derived Growth Factor Receptor Inhibition Using Imatinib in Combination with Docetaxel in the Treatment of Recurrent Non-small Cell Lung Cancer

Infrequent chemoradiation-induced acute esophagitis in the Asian population: A meta-analysis of published clinical trials for unresectable stage III non-small cell lung cancer

Abstract 777: Down-regulation of miR-506 contributes to EGFR-TKI resistance through inducing sonic hedgehog signaling in non-small cell lung cancer

Abstract 485: Modulation of microRNA expression in EGFR-tyrosine kinase inhibitor-resistant non-small cell lung cancer cell lines

Abstract 1481: Determination of microRNA profile in lung cancer cell line treated with chemotherapy cisplatin (C), pemetrexed (P) or PC with bevacizumab (B) and its implication in resistance

Abstract 4528: Comparison of anti-proliferation activity of BEZ 235, a multi-step inhibitor of mTOR pathway, vs. BKM120, a pan PI3K inhibitor, in lung cancer cell lines (LCCL)

Master protocol to assess safety and recommended phase 2 dose of next generation NY-ESO-1–specific TCR T-cells in HLA-A02 patients with synovial sarcoma or non-small cell lung cancer (Substudies 1 and 2)

Abstract 2947: MicroRNA 10b, 27a and 27b are involved in the resistance to treatment with epidermal growth factor tyrosine inhibitor (EGFR-TKI) in EGFR mutant lung cancer cell line

Suchergebnisse filtern